Combretastatin A4 Phosphate Disodium Salt>98.0%(HPLC)20mg

METHYL BENZYLOXYCARBAMATE, 95.0%, 10g

1-(p-Tolyl)piperazine>98.0%(GC)(T)25g

Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylate, 95.0%, 1g

(S)-(-)-3,3'-Dibromo-1,1'-bi-2-naphthol, 98.57%, 25g

4-Ethylphenetole>97.0%(GC)25mL

(4S,4'S)-4,4'-Diisopropyl-1,1'-bis(3-isopropylphenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 100mg

[(2-ethoxy-3-pyridinyl)methyl]amine, 95.0%, 250mg

(R)-2-ethylpyrrolidine hydrochloride, 98%, 5g

Tripropylamine, 100g

(R)-N-((S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl)-2-((S)-1-(N-hydroxyformamido)ethyl)-5-phenylpentanamide, 95%, 5mg

Linoleic Anhydride>90.0%(T)5g

EDTA zinc, min. 96%, for synthesis, 1 kg, plastic packaging.